THE DOSE · A MONTHLY LIFE SCIENCES NEWSLETTER FROM A1 SLIDES
The month in life sciences, translated into what belongs on your slide.
FDA decisions, deals and policy shifts, read for what the headline number doesn't show. Written for medical affairs, HEOR, market access and strategy teams who have to present it next week.
What's in every issue
-
The Signal
One structural shift in the month's news, explained with the data behind it.
-
Capital & Pipeline
The deals and FDA decisions that matter, with the number under the headline.
-
The Deck
One Presentation Standard per issue, a rule for clinical data slides you can apply the same week.
-
Editor's View
A practitioner's read from Vaidehi Shukla.
Every figure is sourced to a primary record, such as FDA letters, SEC filings and company releases. When we get something wrong, we publish the correction in the next issue.
From the latest issue
“The headline is a ceiling. Across these six deals the upfront is between 3% and 16% of the 'up to' figure. A slide that quotes the headline is quoting what could be paid, not what has been.”
Issue 005 · The Orphan Premium · October 2026
Read Issue 005 →All issues
Every issue since June 2026. Each one stands alone: one structural shift, the month's deals and FDA decisions, and one presentation standard.
Issue 005 The Dose The Orphan Premium October 2026
Issue 004 The Dose The Confirmatory Trial Was Always the Point September 2026
Issue 003 The Dose The Denominator Is the Argument August 2026
Issue 002 The Dose The New Map: Who's Really Winning the Global Biopharma Race July 2026
Issue 001 The Dose Strategic intelligence for life science consulting June 2026 The Presentation Standards so far
One standard per issue. Together they form a working checklist for clinical data slides.
Edited by Vaidehi Shukla
About the Author
Vaidehi Shukla
Principal Life Sciences & Market Research, Editor for Newsletter The Dose (UAE)
Vaidehi Shukla is a veteran of the Life Sciences sector with 15 years of strategy consulting and operations experience. With leadership roles at IQVIA and Ipsos, she specializes in navigating the complex regulatory and commercial landscapes of the MENA region and global healthcare markets. At A1 Slides, she brings scientific rigor to clinical data visualization, compliance frameworks, and market research storytelling for healthcare and life sciences clients.
Get the next issue before your next pitch.
One email a month for life sciences teams. Free. Unsubscribe anytime.
One email a month. Unsubscribe anytime.